Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manyun Long

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 14, 2020
Serum Levels of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP), and Cardiac Function in Patients with Unstable Angina PectorisManyun Long, Lang Li
American Journal of Preventive Cardiology|June 16, 2025
Relationships among fibrosis-4, triglyceride-glucose index, and cardiovascular disease: Evidence from the NHANES 2003-2018Ziliang Ye, Manyun Long, Lang Li
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 3, 2025
Serum iron levels predict mortality risk in hypertensive patients: A prospective cohort studyZiliang Ye, Manyun Long, Lang Li
Disease Markers|January 17, 2019
Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary InterventionZiliang Ye, Haili Lu, Manyun Long, et al.
BMC Pharmacology & Toxicology|April 27, 2020
Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysisManyun Long, Ziliang Ye, Jing Zheng, et al.
European Heart Journal|January 5, 2019
RETRACTED: Short-term and long-term effects of a loading dose of atorvastatin before percutaneous coronary intervention on major adverse cardiovascular events in patients with acute coronary syndrome: a meta-analysis of 13 randomized controlled trialsZiliang Ye, Haili Lu, Qiang Su, et al.
Drug Design, Development and Therapy|September 4, 2018
Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trialZiliang Ye, Haili Lu, Qiang Su, et al.
Frontiers in Nutrition|September 22, 2025
Diagnostic value and mediation effects of the visceral adiposity index, triglyceride-glucose index, and platelet-to-HDL ratio in young overweight and obese Chinese adultsHuihe Chen, Shuai Peng, Runa A, et al.
Pharmacology Research & Perspectives|January 15, 2021
Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in ratsJing Zheng, Manyun Long, Zhenbai Qin, et al.
Biomed Research International|September 4, 2020
miR-30e-3p Promotes Cardiomyocyte Autophagy and Inhibits Apoptosis via Regulating Egr-1 during Ischemia/HypoxiaBo Su, Xiantao Wang, Yuhan Sun, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 14, 2020
Serum Levels of Cystatin C, N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP), and Cardiac Function in Patients with Unstable Angina PectorisManyun Long, Lang Li
American Journal of Preventive Cardiology|June 16, 2025
Relationships among fibrosis-4, triglyceride-glucose index, and cardiovascular disease: Evidence from the NHANES 2003-2018Ziliang Ye, Manyun Long, Lang Li
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 3, 2025
Serum iron levels predict mortality risk in hypertensive patients: A prospective cohort studyZiliang Ye, Manyun Long, Lang Li
Disease Markers|January 17, 2019
Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary InterventionZiliang Ye, Haili Lu, Manyun Long, et al.
BMC Pharmacology & Toxicology|April 27, 2020
Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysisManyun Long, Ziliang Ye, Jing Zheng, et al.
European Heart Journal|January 5, 2019
RETRACTED: Short-term and long-term effects of a loading dose of atorvastatin before percutaneous coronary intervention on major adverse cardiovascular events in patients with acute coronary syndrome: a meta-analysis of 13 randomized controlled trialsZiliang Ye, Haili Lu, Qiang Su, et al.
Drug Design, Development and Therapy|September 4, 2018
Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trialZiliang Ye, Haili Lu, Qiang Su, et al.
Frontiers in Nutrition|September 22, 2025
Diagnostic value and mediation effects of the visceral adiposity index, triglyceride-glucose index, and platelet-to-HDL ratio in young overweight and obese Chinese adultsHuihe Chen, Shuai Peng, Runa A, et al.
Pharmacology Research & Perspectives|January 15, 2021
Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in ratsJing Zheng, Manyun Long, Zhenbai Qin, et al.
Biomed Research International|September 4, 2020
miR-30e-3p Promotes Cardiomyocyte Autophagy and Inhibits Apoptosis via Regulating Egr-1 during Ischemia/HypoxiaBo Su, Xiantao Wang, Yuhan Sun, et al.
Pageof 2